Structural biology of 7SK RNP and its interaction with HIV-1 Tat
7SK RNP 的结构生物学及其与 HIV-1 Tat 的相互作用
基本信息
- 批准号:10402809
- 负责人:
- 金额:$ 47.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalActive SitesBindingBinding ProteinsBinding SitesBiochemicalC-terminalCDK9 Protein KinaseCell MaintenanceComplement Factor BComplexCryoelectron MicroscopyCyclin-Dependent KinasesDiseaseDrug TargetingElongation FactorEnzymesGenetic TranscriptionGoalsHIVHIV-1HealthHeart HypertrophyHumanIn VitroLaboratoriesLeadLinkMessenger RNAMethodsMethylationMolecularMolecular ConformationNMR SpectroscopyPhosphotransferasesPlayPositive Transcriptional Elongation Factor BProteinsRNARNA BindingRNA ConformationRNA Polymerase IIRNA Recognition MotifRNA-Protein InteractionRegulationReportingResistanceRoleSmall Nuclear RibonucleoproteinsStressStructureTrans-ActivatorsTransactivationTranscription ElongationTranscription InitiationTranscriptional RegulationU6 small nuclear RNAUntranslated RNAViralVirus ReplicationWorkX-Ray Crystallographycircular RNAcofactorcyclin T1experimental studyin vivoinorganic phosphateinsightleukemia/lymphomapromoterprotein complexrecruitstoichiometrystructural biologytranscription factor
项目摘要
PROJECT SUMMARY/ABSTRACT
The human 7SK RNP is a dynamic assembly of the long non-coding 7SK RNA and cellular proteins that
regulates the activity of positive transcription elongation factor b (P-TEFb). P-TEFb is an essential eukaryotic
transcription factor for mRNA transcription elongation, which regulates the transition from promoter proximal
paused RNA polymerase II (RNAPII) into productive elongation. P-TEFb is also an essential human cofactor
for HIV-1 Tat transactivation and therefore viral replication. The human 7SK core RNP comprises the 331 nt
RNAPIII-transcribed non-coding 7SK RNA, an unusual methyl capping enzyme called MePCE that methylates
the γ phosphate on the RNA 5' terminus, and the La related protein 7, Larp7, that associates with the terminal
hairpin and UUU-3'OH. In the active 7SK snRNP, Hexim and P-TEFb, a heterodimer of Cyclin T1 and the
kinase Cdk9, bind the 7SK core RNP; interaction of P-TEFb in this complex inactivates it by sequestering its
active site. Despite the central role of 7SK in transcription regulation of mRNA, other RNAPII RNAs, and HIV-1
transcription, relatively little is known at a structural or mechanistic level about how cellular proteins assemble
with 7SK RNA to form a functional 7SK RNP or how Tat interacts with it to ultimately release P-TEFb. We will
employ a combination of NMR spectroscopy, X-ray crystallography, and cryo electron microscopy along with
biochemical methods to investigate the structures and assembly of the 7SK core RNP (MePCE–7SK–Larp7)
and 7SK core RNP plus Hexim and P-TEFb (the `active' 7SK RNP) in order to achieve an atomic-level
understanding of this important host RNP for HIV-1 viral replication. These structural studies will lay the
groundwork for elucidating the molecular mechanisms of Tat-Hexim competition in the context of 7SK RNP.
We aim to dissect the potential intermediate steps (i.e. Tat-bound 7SK RNP) that lead to P-TEFb hijacking
from 7SK RNP into the HIV-1 viral super-elongation complex. The results of these experiments will provide
fundamental molecular insights into and a structural basis for drug targeting of this largely structurally
uncharacterized RNP that is essential for HIV-1 transcription and therefore escape from latency.
项目摘要/摘要
人类7SK RNP是非编码的长7SK RNA和细胞蛋白的动态组装,
调节正转录延伸因子b(P-TEFb)的活性。P-TEFb是一种必需的真核生物
调控启动子近端过渡的转录因子--mRNA转录延伸
暂停RNA聚合酶II(RNAPII)进入生产性伸长。P-TEFb也是一种重要的人类辅因子
用于HIV-1TAT的反式激活,从而实现病毒复制。人7SK核心RNP由331个核苷酸组成
RNAPIII-转录的非编码7SK RNA,一种名为MePCE的不寻常的甲基封顶酶,甲基化
RNA5‘末端的γ磷酸,以及与末端相关的La相关蛋白7,Larp7
发夹和UUU-3‘OH。在活性7SK SnRNP、Hexim和P-TEFb中,Cyclin T1和P-TEFb的杂二聚体
激酶CDK9,结合7SK核心RNP;P-TEFb在这个复合体中的相互作用通过隔离其
活动站点。尽管7SK在mRNA、其他RNAPII RNA和HIV-1的转录调控中起着中心作用
转录,在结构或机制水平上对细胞蛋白质如何组装知之甚少
与7SK RNA形成功能性7SK RNP,或Tat如何与其相互作用最终释放P-TEFb。我们会
使用核磁共振光谱、X射线结晶学和低温电子显微镜的组合,以及
生化方法研究7SK核心RNP(MePCE-7SK-Larp7)的结构和组装
以及7SK核心RNP加上Hexim和P-TEFb(主动的7SK RNP),以实现原子级
了解这一重要宿主RNP对HIV-1病毒复制的影响。这些结构研究将为
为阐明7SK RNP背景下TAT-Hexim竞争的分子机制奠定了基础。
我们的目标是剖析导致P-TEFb劫持的潜在中间步骤(即TAT结合的7SK RNP)
从7SK RNP进入HIV-1病毒超延长复合体。这些实验的结果将提供
主要从结构上对药物靶向的基本分子洞察和结构基础
未知的RNP是HIV-1转录所必需的,因此可以逃避潜伏期。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JULI FEIGON其他文献
JULI FEIGON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JULI FEIGON', 18)}}的其他基金
Structural biology of 7SK RNP and its interaction with HIV-1 Tat
7SK RNP 的结构生物学及其与 HIV-1 Tat 的相互作用
- 批准号:
10170271 - 财政年份:2020
- 资助金额:
$ 47.94万 - 项目类别:
Structural biology of 7SK RNP and its interaction with HIV-1 Tat
7SK RNP 的结构生物学及其与 HIV-1 Tat 的相互作用
- 批准号:
10082693 - 财政年份:2020
- 资助金额:
$ 47.94万 - 项目类别:
CS DOMAIN OF THE ESSENTIAL H/ACA RNP ASSEMBLY PROTEIN SHQ1
必需 H/ACA RNP 组装蛋白 SHQ1 的 CS 结构域
- 批准号:
8169256 - 财政年份:2010
- 资助金额:
$ 47.94万 - 项目类别:
相似海外基金
CURCUMIN BINDING MODES IN HIV PROTEASE AND INTEGRASE ACTIVE SITES
HIV 蛋白酶和整合酶活性位点中的姜黄素结合模式
- 批准号:
7955252 - 财政年份:2009
- 资助金额:
$ 47.94万 - 项目类别:
CURCUMIN BINDING MODES IN HIV PROTEASE AND INTEGRASE ACTIVE SITES
HIV 蛋白酶和整合酶活性位点中的姜黄素结合模式
- 批准号:
7722358 - 财政年份:2008
- 资助金额:
$ 47.94万 - 项目类别:
CURCUMIN BINDING MODES IN HIV PROTEASE AND INTEGRASE ACTIVE SITES
HIV 蛋白酶和整合酶活性位点中的姜黄素结合模式
- 批准号:
7601705 - 财政年份:2007
- 资助金额:
$ 47.94万 - 项目类别:
CURCUMIN BINDING MODES IN HIV PROTEASE AND INTEGRASE ACTIVE SITES
HIV 蛋白酶和整合酶活性位点中的姜黄素结合模式
- 批准号:
7358721 - 财政年份:2006
- 资助金额:
$ 47.94万 - 项目类别:
Biomaterial having active sites of collagen-binding adhesion molecules (CMP and RGD-CAP)
具有胶原蛋白结合粘附分子活性位点的生物材料(CMP 和 RGD-CAP)
- 批准号:
09557146 - 财政年份:1997
- 资助金额:
$ 47.94万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
PEPTIDES BASED ON ACTIVE SITES OF ACTIN BINDING PROTEINS
基于肌动蛋白结合蛋白活性位点的肽
- 批准号:
2291586 - 财政年份:1992
- 资助金额:
$ 47.94万 - 项目类别:
PEPTIDES BASED ON ACTIVE SITES OF ACTIN-BINDING PROTEINS
基于肌动蛋白结合蛋白活性位点的肽
- 批准号:
3432528 - 财政年份:1992
- 资助金额:
$ 47.94万 - 项目类别:
PEPTIDES BASED ON ACTIVE SITES OF ACTIN BINDING PROTEINS
基于肌动蛋白结合蛋白活性位点的肽
- 批准号:
2546673 - 财政年份:1992
- 资助金额:
$ 47.94万 - 项目类别:
PEPTIDES BASED ON ACTIVE SITES OF ACTIN-BINDING PROTEINS
基于肌动蛋白结合蛋白活性位点的肽
- 批准号:
3432526 - 财政年份:1992
- 资助金额:
$ 47.94万 - 项目类别:
PEPTIDES BASED ON ACTIVE SITES OF ACTIN BINDING PROTEINS
基于肌动蛋白结合蛋白活性位点的肽
- 批准号:
2291587 - 财政年份:1992
- 资助金额:
$ 47.94万 - 项目类别: